Rocket Pharmaceuticals (RCKT): See Remarks sold ~$40K
Jonathan David Schwartz, See Remarks at Rocket Pharmaceuticals, sold ~$40K of Rocket Pharmaceuticals shares.
- ~$40K
- Approx. value · 3,097 sh @ $13.05
- 164K
- Holds after · shares reported
- Traded
- Nov 21, 2024
- Filed
- Feb 27, 2025
What stands out in this filing
- The sale was 1.9% of the shares this insider held before it; the filing reports 163,852 shares afterwards.
- 3,097 shares at an average of $13.05 each, as reported on the form.
- Footnote references tax withholding.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 17, 2024InsiderOfficer sold ~$64K of RCKT shares in the open market
- Aug 16, 2024InsiderOfficer sold ~$50K of RCKT shares in the open market
- Oct 31, 2024Insider · 2 peopleInsiders: 2 sales (~$66K)
- Nov 21, 2024 · this disclosureInsiderOfficer sold ~$40K of RCKT shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Rocket Pharmaceuticals
For Rocket Pharmaceuticals, OQRO holds 13 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RCKT page.
Other recent filings by Jonathan David Schwartz, See Remarks
- SEC Form 4 at Rocket Pharmaceuticals (RCKT)Aug 20, 2025
- SEC Form 4 at Rocket Pharmaceuticals (RCKT)Aug 20, 2025
- SEC Form 4 at Rocket Pharmaceuticals (RCKT)Aug 18, 2025
- SEC Form 4 at Rocket Pharmaceuticals (RCKT)May 22, 2025
- SEC Form 4 at Rocket Pharmaceuticals (RCKT)May 20, 2025
The full history of Jonathan David Schwartz, See Remarks is on the profile page.
How this filing works
Explore the data
Common questions
Which Rocket Pharmaceuticals (RCKT) insider traded, and how much?
Jonathan David Schwartz, See Remarks at Rocket Pharmaceuticals, sold ~$40K of Rocket Pharmaceuticals shares. 3,097 shares at $13.05.
When did it happen, and when was it made public?
Traded: Nov 21, 2024. Filed: Feb 27, 2025. That is 98 days between the two dates.
What stands out in this filing?
The sale was 1.9% of the shares this insider held before it; the filing reports 163,852 shares afterwards. 3,097 shares at an average of $13.05 each, as reported on the form. Footnote references tax withholding.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Rocket Pharmaceuticals recently?
For Rocket Pharmaceuticals, OQRO holds 13 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the RCKT page.
Does this mean RCKT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Rocket Pharmaceuticals
- SEC Form 4Nov 20, 2026
- SEC Form 4Nov 20, 2026
- SEC Form 144Nov 18, 2026
- SEC Form 144Nov 18, 2026
- SEC Form 4Nov 17, 2026
- SEC Form 4Nov 17, 2026
Everything OQRO holds on this company is on its RCKT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
